Diminished HIV-Specific CTL Activity Is Associated with Lower Type 1 and Enhanced Type 2 Responses to HIV-Specific Peptides During Perinatal HIV Infection

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 6029-6036

  Wasik, Thomas J ^a   Jagodzinski, Paul P ^a   Hyjek, Elizabeth M ^a   Wustner, Jason ^a   Trinchieri, Giorgio ^b   Lischner, Harold W ^c   Kozbor, Danuta ^a,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WISTAR INSTITUTE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY; PEPTIDE; VIRUS ENVELOPE PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; MONONUCLEAR CELL; PRESCHOOL CHILD; TH2 CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CELLS, CULTURED; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; PEPTIDES; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TH2 CELLS; VIRAL ENVELOPE PROTEINS;

EID: 0031570383     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Blanche, S., M. Tardieu, A. M., Duliege, C. Rouzioux, F. LeDeist, K. Fukunaga, M. Caniglia, C. Jacomet, A. Massiah, and C. Griscelli. 1990. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency viras infection. Am. J. Dis. Child. 144:1210.
2. Wilson, C. B. 1986. Immunological basis for increased susceptibility of neonates to infection. J. Pediatr. 108:1.
3. Andersson, U., A. G. Bird, S. Britton, and R. Palacios. 1981. Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol. Rev. 57:5.
4. McCune, J. M. 1991. HIV-1: the infective process in vivo. Cell 64:351.
5. Cheynier, R., P. Langlade-Demoyen, M. R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22:2211.
6. Luzuriaga, K., D. Holmes, A. Hereema, J. Wong, and D. L. Panicali. 1995. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154:433.
7. Clerici, M., A. V. Sison, J. A. Berzofsky, T. A. Rakusan, C. D. Brandt, M. Ellaurie, M. L. Villa, Ch. Colie, D. J. Venzon, J. L. Sever, and G. M. Shearer. 1993. Cellular immune factors associated with mother-to-infant transmission of HIV. AIDS 7:1427.
8. Ehlers, S., and K. A. Smith. 1991. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med. 173:25.
9. Bach, J. F. 1978. Definition of (immunologic) memory. In Immunology. J. F. Bach, ed. John Wiley and Sons, Inc., New York, p. 848.
10. Lewis, D. B., C. C. Yu, J. Meyer, B. K. English, S. J. Kahn, and C. B. Wilson. 1991. Cellular and molecular mechanisms for reduced interleukin-4 and interferon-γ production by neonatal T cells. J. Clin. Invest. 87:194.
11. Hyjek, E., H. W. Lischner, T. Hyslop, J. Bartkowiak, M. Kubin, G. Trinchieri, and D. Kozbor. 1995. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J. Immunol. 155:4060.
12. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. Coffman. 1986. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 130:2348.
13. Romagnani, S. 1991. Human Th1 and Th2 subsets: doubt no more. Immunol. Today 12:256.
14. Clerici, M., and G. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575.
15. H0 cells. Science 265:244.
16. Centers for Disease Control. 1994. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morbid. Mortal. Wkly. Rep. 43:1.
17. Berzofsky, J. A., C. D. Pendleton, M. Clerici, J. Ahlers, D. R. Lucey, S. D. Putney, and G. M. Shearer. 1991. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types. J. Clin. Invest. 88:876.
18. Otvos, L., Jr., L. Urge, Z. Q. Xiang, G. R. Krivulka, L. Nagy, G. I. Szendrei, and H. C. Ertl. 1994. Glycosylation of synthetic T helper cell epitopic peptides influences their antigenic potency and conformation in a sugar location-specific manner. Biochim. Biophys. Acta 1224:68.
19. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hendrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759.
20. Murphy, M., R. Loudon, M. Kobayashi, and G. Trinchieri. 1986. γ interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/ monocyte colony formation. J. Exp. Med. 164:263.
21. van der Pouw-Kraan, T., R. de Jong, and L. Aarden. 1993. Development of human TH1 and TH2 cytokine responses: the cytokine production profile of T cells is dictated by the primary in vitro stimulus. Eur. J. Immunol. 23:1.
22. Kozbor, D., E. Hyjek, R. Wiaderkiewicz, Z. Wang, M. Wang, and E. Loh. 1993. Competitor mRNA fragments for quantitation of cytokine specific transcripts in cell lysates. Mol. Immunol. 30:1.
23. Jagodzinski, P. P., R. Wiaderkiewicz, G. Kurzawski, M. Kloczewiak, H. Nakashima, E. Hyjek, N. Yamamoto, T. Uryu, Y. Kaneko, M. R. Posner, and D. Kozbor. 1994. Mechanism of inhibitory effect of curdlan sulfate on HIV-1 infection in vitro. Virology 202:735.
24. Takahashi, H., S. Merli, S. D. Putney, R. Houghten, and B. Moss. 1989. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 246:118.
25. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403.
26. Koenig, S., T. R. Fuerst, L. V. Wood, R. M. Woods, and J. A Suzich. 1990. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J. Immunol. 145:127.
27. Flexner, C., and S. S. Broyles. 1988. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses. Virology 166:339.
28. Kozbor, D., and J. C. Roder. 1981. Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J. Immunol. 127:1275.
29. Luzuriaga, K., P. McQuilken, A. Alimenti, R. A. Hesselton, M. Somasundaran, and J. L. Sullivan. 1993. Early viremia and immune responses in vertical HIV-1 infection. J. Infect. Dis. 167:1008.
30. Koup, R. A., C. A. Pikora, K. Luzuriaga, D. B. Brettler, E. S. Day, G. P. Mazzara, and J. L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174:1593.
31. Strijbosh, L. W. G., W. A. Buurman, R. J. M. M. Does, P. H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays. Experimental design and statistical analysis. J. Immunol. Methods 97:133.
32. Lehmann, E. L. 1975. Nonparametrics: Statistical Methods Based tin Ranks. Holden-Day, San Francisco, p. 300.
33. Winer, B. J. 1971. Design and analysis of factorial experiments. In Statistical Principles in Experimental Design. W. Maytham, A. Shapiro, J. Stern, eds. McGraw-Hill, New York, pp. 399-400.
34. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowski, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
35. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H. N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012.
36. Klein, M. R., C. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. M. Keet, J.-K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
37. Giovarelli, M., A. Santoni, C. Jemma, T. Musso, A. M. Giuffrida, G. Cavallo, S. Landolfo, and G. Forni. 1988. Obligatory role of IFN-γ in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. J. Immunol. 141:2831.
38. Landolfo, S., F. Cofano, M. Giovarelli, M. Prat, G. Cavallo, and G. Forni. 1985. Inhibition of interferon-gamma suppresses histocompatibility antigen recognition by T-lymphocytes. Science 229:176.
39. Wolinsky, S. M., C. M. Wike, B. T. M. Korber, C. Hutto, W. Parks, L. L. Rosenblum, K. J. Kunstman, M. R. Furtado, and J. L. Munoz. 1992. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255:1134.
40. Lammers, S. J., J. W. Sleasman, J. X. She, K. A. Barre, S. M. Pomeroy, D. J. Barrett, and M. M. Goodenow. 1993. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo. J. Virol. 67:3957.
41. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, and C. R. Rizza. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453.
42. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
43. Klenerman, P., U. C. Meier, R. E. Phillips, and A. J. McMichael. 1995. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur. J. Immunol. 25:1927.
44. Clerici, M., E. Roilides, K. M. Butler, L. De Palma, D. Venzon, G. M. Shearer, and P. A. Pizzo. 1992. Changes in T-helper cell function in human immunodeficiency virus infected children during didanosine therapy as a measure of antiretroviral activity. Blood 80:2196.
45. Hoffenbach, A., P. Langlande-Demoyen, G. Dadaglio, E. Vilmer, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452.